Cargando…
The predictive value of methylene blue dye as a single technique in breast cancer sentinel node biopsy: a study from Dharmais Cancer Hospital
BACKGROUND: Axillary lymph node dissection (ALND) has been the standard treatment of breast cancer axillary staging in Indonesia. The limited facilities of radioisotope tracer and isosulfan or patent blue dye (PBD) have been the major obstacles to perform sentinel node biopsy (SNB) in our country. W...
Autores principales: | Brahma, Bayu, Putri, Rizky Ifandriani, Karsono, Ramadhan, Andinata, Bob, Gautama, Walta, Sari, Lenny, Haryono, Samuel J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5297091/ https://www.ncbi.nlm.nih.gov/pubmed/28173818 http://dx.doi.org/10.1186/s12957-017-1113-8 |
Ejemplares similares
-
Clinical Utility of BRAF, NRAS, and TERT Promoter Mutation in Preoperative Thyroid Fine-Needle Aspiration Biopsy: A Diagnostic Study From Dharmais Cancer Hospital
por: Perdana, Adhitya Bayu, et al.
Publicado: (2020) -
Can methylene blue dye be used as an alternative to patent blue dye to find the sentinel lymph node in breast cancer surgery?
por: Fattahi, Asieh Sadat, et al.
Publicado: (2014) -
Retrospective analysis of sentinel lymph node biopsy using methylene blue dye for early breast cancer
por: Yang, Shan, et al.
Publicado: (2021) -
ESR1 PvuII polymorphism: from risk factor to prognostic and predictive factor of the success of primary systemic therapy in advanced breast cancer
por: Karsono, Ramadhan, et al.
Publicado: (2021) -
Factors that affect the false negative rate of sentinel lymph node mapping with methylene blue dye alone in breast cancer
por: Li, Huang, et al.
Publicado: (2019)